Cramer's lightning round: Why I'm wary of Gilead's growth

It's that time again! Jim Cramer rang the lightning round bell for Nov. 22, which means he gave his take on caller favorite stocks at rapid speed:

Gilead Sciences: "Gilead has to do something! They have to use some of their cash to buy someone, because they have no growth. And I cannot recommend a biotech stock that has no growth."

California Resources Corp: "It has finally taken off. This is a spinoff. I prefer higher quality oil companies. I go over them all the time, but I think the service company Schlumberger, which my charitable trust owns, is an even better bet now that California Resources has moved so much."

Frontier Communications Corp: "Too risky for me. Frankly, I'm going to have to throw a red flag there. It's just too risky, I'm sorry."

Devon Energy Corp: "Devon Energy is fine. Not as good as some others, like an Anadarko, but I like Devon."

Dycom Industries: "I have to find out whether that is an overreaction or not. I can't have a stock drop 20 points on me and I'm trying to figure out whether it's just like 'hey snap it up.' I have to do more work on Dycom. And you are owed that, so let me come back."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com